Form 4: Avid Bioservices Chief Operations Officer Richard A. Richieri Disposes of Shares and Options in Merger

Richard A. Richieri, Chief Operations Officer of Avid Bioservices, Inc., reports the disposal of common stock, stock options, restricted stock units, and performance stock units due to the merger with Space Mergerco, Inc.

Summary

• Richard A. Richieri, the Chief Operations Officer of Avid Bioservices, Inc. (CDMO), filed a Form 4 on February 7, 2025, reporting transactions that occurred on February 5, 2025.
• The transactions relate to the merger of Space Mergerco, Inc. with and into Avid Bioservices, Inc. pursuant to an agreement dated November 6, 2024.
• Richieri disposed of 49,535 shares of common stock, as well as 8,785 shares held indirectly by his spouse, for $12.50 per share.
• He also disposed of various stock options, restricted stock units (RSUs), and performance stock units (PSUs), which were converted into the right to receive cash payments.
• The cash payment for vested options was calculated based on the excess of the merger consideration ($12.50) over the exercise price.
• Unvested RSUs and PSUs were converted into the right to receive $12.50 per share.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports the execution of a merger agreement and the resulting transactions. It doesn't convey positive or negative implications beyond the factual reporting of the events.

Future Outlook

The document does not contain any specific forward-looking statements beyond the completion of the merger.

Industry Context

This announcement reflects a change in ownership structure for Avid Bioservices, a contract development and manufacturing organization (CDMO), due to a merger. Mergers and acquisitions are common in the CDMO industry as companies seek to expand their capabilities, market reach, or consolidate operations.

Comparison to Industry Standards

• It is difficult to compare this announcement to industry standards as it is an individual filing related to a merger.
• However, mergers in the CDMO space are often valued based on multiples of revenue or EBITDA, which are not disclosed in this document.
• Comparable transactions would need to be analyzed to determine if the $12.50 per share merger consideration is in line with industry norms.

Stakeholder Impact

• Shareholders received $12.50 per share as part of the merger consideration.
• Employees may experience changes as a result of the merger, although this is not detailed in the document.

Key Dates

Keywords

Form 4, Avid Bioservices, CDMO, Richard A. Richieri, Merger, Space Mergerco, Stock Options, Restricted Stock Units, Performance Stock Units, Beneficial Ownership, Disposition